echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > npj Parkinsons Dis: Parkinson's disease, the inflammasome facilitates the assessment of the condition

    npj Parkinsons Dis: Parkinson's disease, the inflammasome facilitates the assessment of the condition

    • Last Update: 2022-04-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Parkinson's disease (PD) is a complex age-related neurodegenerative disorder affecting multiple systems and clinically characterized by a range of motor and non-motor symptoms
    .


    Diagnostic tests and neuroprotective strategies have been slow to emerge, in part because the molecular mechanisms underlying disease initiation and progression have not been fully defined


    diagnosis

    Figure 1 Title of the paper

    Figure 1 Title of the paper

    Neuroinflammation and loss of diencephalic dopaminergic neurons have been observed in postmortem tissue from Parkinson's disease patients, and it is widely believed that inflammation contributes to the progression of neurodegenerative processes
    .

    Evidence supporting a role for neuroinflammation in PD comes from animal models and epidemiological studies showing that the use of nonsteroidal anti-inflammatory drugs (NSAIDs), particularly ibuprofen, is associated with a reduced risk of developing PD
    .

    It is estimated that 30-70% of dopaminergic neurons have been lost by the time motor symptoms develop and PD is diagnosed
    .


    We must leverage our growing understanding of PD-related pathophysiology, such as inflammation, to help understand the complexity of PD and to inform the development of preventive measures and neuroprotective strategies to avoid onset or slow disease progression


    prevention

    Inflammasomes are proinflammatory intracellular complexes defined by proteins belonging to the nucleotide-binding domain-like receptors (NLRs), absent melanoma 2-like receptors (ALRs), or Pyrin pattern recognition receptor families
    .


    Assembly of the inflammasome complex drives caspase-1 catalysis, initiating cytokine maturation and secretion, and possibly febrile disease, an inflammatory subclass of programmed cell death


    Inflammasomes are increasingly linked to neurodegenerative diseases, especially Alzheimer's disease and Parkinson's disease
    .


    This link is intuitive because NLRP3 inflammasome activity can be triggered by germ-free cellular stress associated with neurodegenerative disease pathology, including cell death, mitochondrial stress, reactive oxygen species (ROS), and proteinaceous damage, including amyloid -β and α-synuclein aggregation


    Growing evidence links the NLRP3 inflammasome to PD, including a recent report describing the Nlrp3 inflammasome in response to fibrillar α-synuclein exposure, ROS production, and the occupational toxicant manganese; these three germ-free inflammatory triggers implicated in the development and pathophysiology of PD
    .

    In this way, Faith L Anderson of the Geisel School of Medicine at Dartmouth College in the United States and others explored the relationship between the inflammasome and PD
    .

    They found:

    The NLRP3 inflammasome is expressed in multiple cell types of the human diencephalon
    .

    Figure 2 The correlation between NLR and PD pathological changes

    Figure 2 The correlation between NLR and PD pathological changes

    In addition, polymorphisms of NLRP3 were associated with a reduced risk of PD;

    In addition, polymorphisms of NLRP3 were associated with a reduced risk of PD;

    Inactivation of NLRP3 is neuroprotective in a toxicant-based mouse model of PD
    .

    Inactivation of NLRP3 is neuroprotective in a toxicant-based mouse model of PD
    .


    The significance of this study is the discovery that inactivation of the NLRP3 inflammasome may benefit PD patients
    .

    The significance of this study is the discovery that inactivation of the NLRP3 inflammasome may benefit PD patients
    .



    Original source:
    Anderson FL, von Herrmann KM, Andrew AS, et al.


    Plasma-borne indicators of inflammasome activity in Parkinson's disease patients.
    npj Parkinsons Dis.



    Original source:
    Anderson FL, von Herrmann KM, Andrew AS, et al.
    Plasma-borne indicators of inflammasome activity in Parkinson's disease patients.
    npj Parkinsons Dis.
    2021;7(1):2.
    doi:10.
    1038/s41531-020-00147 -6 Plasma-borne indicators of inflammasome activity in Parkinson's disease patients.
    npj Parkinsons Dis.
    Leave a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.